[12] Patent
[11] Patent No.:GC0009355  
[45] Date of Publishing the Grant of the Patent: 31/Dec /2018                56/2018  
Number of the Decision to Grant the Patent:2018/141494
Date of the Decision to Grant the Patent:12/Dec/2018

[21] Application No.:GCC/P/2007/8873

[22] Filing Date:11/8/2007

[72] Inventors:1- Ramil F. Latypov،2- Gayathri Ratnaswamy،3- Richard L. Remmele,Jr.،4- Dingjiang Liu،5- William J. Callahan

[73] Owner: AMGEN Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA

[74] Agent: Suleiman I. Al-Ammar Law Office

  

 

  

[51]IPC:
Int. Cl.: A61K 39/395, A61K 39/00 (2006.01)

[56] Cited Documents:

-CN 1596266 A (AMGEN INC) 16 March 2005  
Examiner: Nouf AlNassban

[54] LYOPHILIZED THERAPEUTIC PEPTIBODY FORMULATIONS
[57] Abstract: The present invention provides long-term stable formulations of a lyophilized therapeutic peptibody and methods for making a lyophilized composition comprising a therapeutic peptibody.
No. of claims: 8     No. of figures: 8


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.